Publication:
Comprehensive analysis of the HLA class I and the HLA class II Alleles in Patients with Takayasu Arteritis: Relationship with Clinical Patterns of the Disease and Prognosis

dc.contributor.authorStojanovic, Maja (57201074079)
dc.contributor.authorAndric, Zorana (23033104600)
dc.contributor.authorPopadic, Dusan (6602255798)
dc.contributor.authorStanojevic, Marija Stankovic (57386467100)
dc.contributor.authorMiskovic, Rada (56394650000)
dc.contributor.authorJovanovic, Dragana (7102247807)
dc.contributor.authorPeric-Popadic, Aleksandra (6603261722)
dc.contributor.authorBolpacic, Jasna (6507378541)
dc.contributor.authorTomic-Spiric, Vesna (6603500319)
dc.contributor.authorRaškovic, Sanvila (6602461528)
dc.date.accessioned2025-06-12T13:12:55Z
dc.date.available2025-06-12T13:12:55Z
dc.date.issued2021
dc.description.abstractBackground: Takayasu arteritis (TA) is a systemic vasculitis, affecting mainly the aorta and its branches. Objective: To analyze the HLA class I and class II alleles in patients with TA and explore their relationship with clinical and demographic characteristics, and potential significance in prognosis. Methods: Twenty-five, unrelated TA patients were genotyped for HLA-A, HLA-B, HLA-C, HLA-DRB1, and the HLA-DQB1 loci. The frequencies of the HLA-A, HLA-B, and the HLA-DRB1 were compared with a control group of 1992, while the HLA-C and the HLA-DQB1 were compared with a group of 159 healthy, unrelated individuals. Results: Among TA patients, 5/25 (20%) were identified as the HLA-B*52 carriers. There was a significant difference in the HLA-B*52 allele frequency in the TA patients (10%) compared with the healthy controls (1.2%). Moreover, presence of the HLA-B*52 was associated with significantly earlier disease onset, more severe clinical presentations, and a poorer response to treatment. The HLA-C*03 was detected in 32% of patients and was present exclusively in those with a clinically mild form of the TA, indicating a putative protective effect. Conclusion: These findings indicate that the HLA-B*52 allele contributes to a higher susceptibility to the TA whereas the HLA-C*03, can be a protective factor in the TA. © 2021, Shiraz University of Medical Sciences. All rights reserved.
dc.identifier.urihttps://doi.org/10.22034/iji.2021.88846.1911
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85122908235&doi=10.22034%2fiji.2021.88846.1911&partnerID=40&md5=80f269c3fda792bb36dd18b7bfb466ac
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3922
dc.subjectBiomarkers
dc.subjectHLA
dc.subjectImmunogenetics
dc.subjectTakayasu arteritis
dc.subjectVasculitis
dc.titleComprehensive analysis of the HLA class I and the HLA class II Alleles in Patients with Takayasu Arteritis: Relationship with Clinical Patterns of the Disease and Prognosis
dspace.entity.typePublication

Files